Walgreen Crunches Numbers from USA Drug Buy

According to Walgreen Co.'s earnings report for its fiscal first quarter, which ended Nov. 30, buying USA Drug from Stephen L. LaFrance Holdings Inc. cost Walgreen's $416 million.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access articles older than 15 days.
Articles newer than 15 days are not included in this offer.

Purchase Now

Already have archive access? Login to view this article.